rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
13
|
pubmed:dateCreated |
2006-7-4
|
pubmed:abstractText |
Activation of mitogen-activated protein kinase (MAPK) and members of the Akt pathway have been shown to promote cell proliferation, survival, and resistance to radiation. This study was conducted to determine whether any of these markers are associated with survival time and response to radiation in glioblastoma.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adipokines,
http://linkedlifedata.com/resource/pubmed/chemical/CHI3L1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Lectins,
http://linkedlifedata.com/resource/pubmed/chemical/MTOR protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt,
http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6 Kinases, 70-kDa,
http://linkedlifedata.com/resource/pubmed/chemical/TOR Serine-Threonine Kinases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1078-0432
|
pubmed:author |
pubmed-author:AldapeKenneth DKD,
pubmed-author:BarkerFredrick GFG3rd,
pubmed-author:ChangSusanS,
pubmed-author:ColmanHowardH,
pubmed-author:FullerGregory NGN,
pubmed-author:HeimbergerAmy BAB,
pubmed-author:LiuJuinn-LinJL,
pubmed-author:LiuLL,
pubmed-author:PelloskiChristopher ECE,
pubmed-author:PradosMichaelM,
pubmed-author:SukiDimaD,
pubmed-author:WooShaio YSY,
pubmed-author:YungW K AlfredWK,
pubmed-author:ZhangLiL
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3935-41
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16818690-Adipokines,
pubmed-meshheading:16818690-Adolescent,
pubmed-meshheading:16818690-Adult,
pubmed-meshheading:16818690-Aged,
pubmed-meshheading:16818690-Aged, 80 and over,
pubmed-meshheading:16818690-Cohort Studies,
pubmed-meshheading:16818690-Follow-Up Studies,
pubmed-meshheading:16818690-Glioblastoma,
pubmed-meshheading:16818690-Glycoproteins,
pubmed-meshheading:16818690-Humans,
pubmed-meshheading:16818690-Immunohistochemistry,
pubmed-meshheading:16818690-Kaplan-Meier Estimate,
pubmed-meshheading:16818690-Lectins,
pubmed-meshheading:16818690-Middle Aged,
pubmed-meshheading:16818690-Mitogen-Activated Protein Kinases,
pubmed-meshheading:16818690-Phosphorylation,
pubmed-meshheading:16818690-Predictive Value of Tests,
pubmed-meshheading:16818690-Prognosis,
pubmed-meshheading:16818690-Protein Kinases,
pubmed-meshheading:16818690-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:16818690-Retrospective Studies,
pubmed-meshheading:16818690-Ribosomal Protein S6 Kinases, 70-kDa,
pubmed-meshheading:16818690-Signal Transduction,
pubmed-meshheading:16818690-Survival Rate,
pubmed-meshheading:16818690-TOR Serine-Threonine Kinases,
pubmed-meshheading:16818690-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.
|
pubmed:affiliation |
Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
|
pubmed:publicationType |
Journal Article
|